跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 文亮
教授
生醫科學與工程博士學位學程
智慧型藥物與智能生物裝置研究中心
https://orcid.org/0000-0003-4308-3128
h-index
h10-index
h5-index
4665
引文
28
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3695
引文
20
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
420
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2025
每年研究成果
概覽
指紋
網路
計畫
(7)
研究成果
(89)
獎項
(3)
類似的個人檔案
(6)
指紋
查看啟用 Wen-Liang Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
β-lactoglobulin (β-Lg)
100%
Taiwan
88%
Monoclonal Antibody
81%
Out-of-hospital Cardiac Arrest
80%
Pediatric
52%
Nanotopography
52%
Artificial Microenvironment
51%
Tantalum Oxide
50%
Cell Proliferation
50%
Nanodots
48%
Internet of Things
48%
Haptoglobin
46%
Major Depressive Disorder
46%
Point-of-care
46%
Cell Behavior
45%
MicroRNA
45%
Non-traumatic
41%
Cardiomyocytes
41%
Congenital muscular Dystrophy
38%
Milk
35%
Limb-girdle muscular Dystrophy
35%
Neurological Outcome
33%
Dry Milk
32%
Cell Growth
32%
MiRTarBase
31%
MiRNA-mRNA Interaction
31%
Initial Attack
31%
Migration Invasion
31%
Distant Metastasis
31%
Chronic Kidney Disease
31%
Nanochips
31%
Osteoblast Cells
31%
Noninvasive Ventilation
31%
Epinephrine
31%
Mechanical In-exsufflator
31%
Population-based
31%
National Population
31%
Electrochemical Biosensor
31%
COVID-19
31%
Systematic Meta-analysis
31%
Meta-analysis
31%
Survivors
28%
Internet of Things Devices
28%
Gastric Cancer
26%
Cell Characteristics
24%
Acute Respiratory Failure
24%
Return of Spontaneous Circulation
22%
Neuromuscular Disease
22%
Medical Center
22%
Epithelial-mesenchymal Transition
21%
Medicine and Dentistry
Out of Hospital Cardiac Arrest
93%
Pediatrics
59%
Muscular Dystrophy
46%
Major Depressive Episode
46%
Limb Girdle Muscular Dystrophy
41%
Biological Marker
31%
Noninvasive Ventilation
31%
Epinephrine
31%
Hemodynamic
31%
Non Small Cell Lung Cancer
31%
Diseases
27%
Emergency Department
26%
Malignant Neoplasm
25%
Oxidoreductase
25%
Acute Respiratory Failure
24%
Next Generation Sequencing
23%
Neuromuscular Disease
22%
Cancer Cell
22%
Return of Spontaneous Circulation
21%
Myopathy
20%
Mechanical Ventilation
20%
Percutaneous Coronary Intervention
19%
Metastatic Carcinoma
19%
Resuscitation
18%
In Vitro
17%
Spinal Muscular Atrophy
17%
Extracellular Matrix
17%
Prevalence
17%
Respiratory Failure
17%
Diagnosis
16%
Myocardial Infarction
16%
Infection
16%
Cell Proliferation
16%
Clinical Feature
16%
Chronic Kidney Disease
15%
Gross Motor Function Measure
15%
Placebo
15%
Steatosis
15%
Cataract
15%
Monoclonal Antibody
15%
Cardiovascular System
15%
Cardiac Troponin
15%
ST Segment Elevation Myocardial Infarction
15%
Urticaria
15%
Oral Cancer
15%
Cardiac Muscle Cell
15%
Mesenchymal-Epithelial Transition
15%
Distant Metastasis
15%
Cytochrome C Oxidase
15%
Chronic Obstructive Pulmonary Disease
15%
